The National Institute for Health and Care Excellence (NICE) has recommended enfortumab vedotin with pembrolizumab (EVP) to ...

Our session at this year’s International Pharmaceutical Federation (FIP) World Congress — entitled, ‘Global initiatives to ...

The Royal College of Pharmacy’s (RCPharm) transition strategy “lays the foundations for pharmacy to thrive into the future”, ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has awarded contracts to three private companies, in what it ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a gene-editing treatment for severe sickle-cell ...

Delivery of integrated care board (ICB) functions have not been adequately protected during a reorganisation of the bodies, ...

Senior hospital pharmacists should be involved in planning and decision-making if corridor care for patients is required, the ...

The number of people taking part in industry clinical trials in the NHS has fallen for the fifth year in a row, data ...

Insulin pen devices can present challenges for people with certain disabilities, the Health Services Safety Investigations ...

A report from the Association of the British Pharmaceutical Industry (ABPI) has identified ‘unwarranted variation’ in patient ...

Adding a personalised messenger RNA (mRNA) cancer vaccine to pembrolizumab — an immunotherapy drug — after surgery for ...

Fewer than 2% of community pharmacies carried out a consultation under the NHS community pharmacy smoking cessation service ...